Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Cancer Sci ; 111(12): 4417-4428, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33016509

RESUMO

Prolonged hypersecretion of catecholamine induced by chronic stress may correlate with malignant progression of cancer. ß2-adrenergic receptor (ß2-AR) overexpressed in certain cancer cells may translate the signals from neuroendocrine system to malignant signals by interacting with oncoproteins, such as Her2. In the present study, we demonstrate that catecholamine stimulation activates the expression and proteolytic activity of ADAM10 by modulating the expression of miR-199a-5p and SIRT1 and also confirm that catecholamine induction triggers the activities of γ-secretase, leading to shedding of Her2 extracellular domain (ECD) by ADAM10 and subsequent intramembranous cleavage of Her2 intracellular domain (ICD) by presenilin-dependent γ-secretase, nuclear translocation of Her2 ICD, and enhanced transcription of tumor metastasis-associated gene COX-2. Chronic stimulation of catecholamine strongly promotes the invasive activities of cancer cells in vitro and spontaneous tumor lung metastasis in mice. Furthermore, nuclear localization of Her2 was significantly correlated with overexpression of ß2-AR in human breast cancer tissues, indicating that catecholamine-induced ß2-AR activation plays decisive roles in tumor metastasis. Our data also reveal that an unknown mechanism by which the regulated intramembrane proteolysis (RIP) initiated by ß2-AR-mediated signaling controls a novel Her2-mediated signaling transduction.


Assuntos
Catecolaminas/farmacologia , Núcleo Celular/metabolismo , Metástase Neoplásica , Receptor ErbB-2/metabolismo , Receptores Adrenérgicos beta 2/metabolismo , Proteína ADAM10/metabolismo , Agonistas de Receptores Adrenérgicos beta 2/farmacologia , Secretases da Proteína Precursora do Amiloide/metabolismo , Animais , Neoplasias da Mama/metabolismo , Linhagem Celular Tumoral , Ciclo-Oxigenase 2/genética , Feminino , Humanos , Isoproterenol/farmacologia , Neoplasias Pulmonares/secundário , Células MCF-7 , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , MicroRNAs/metabolismo , Invasividade Neoplásica , Proteólise , Transdução de Sinais , Sirtuína 1/metabolismo , Ativação Transcricional
2.
Environ Monit Assess ; 192(10): 628, 2020 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-32902735

RESUMO

To provide more precise understanding of water quality changes, continuous sampling is being used more in surface water quality monitoring networks. However, it remains unclear how much improvement continuous monitoring provides over spot sampling, in identifying water quality changes over time. This study aims (1) to assess our ability to detect trends using water quality data of both high and low frequencies and (2) to assess the value of using high-frequency data as a surrogate to help detect trends in other constituents. Statistical regression models were used to identify temporal trends and then to assess the trend detection power of high-frequency (15 min) and low-frequency (monthly) data for turbidity and electrical conductivity (EC) data collected across Victoria, Australia. In addition, we developed surrogate models to simulate five sediment and nutrients constituents from runoff, turbidity and EC. A simulation-based statistical approach was then used to the compare the power to detect trends between the low- and high-frequency water quality records. Results show that high-frequency sampling shows clear benefits in trend detection power for turbidity, EC, as well as simulated sediment and nutrients, especially over short data periods. For detecting a 1% annual trend with 5 years of data, up to 97% and 94% improvements on the trend detection probability are offered by high-frequency data compared with monthly data, for turbidity and EC, respectively. Our results highlight the benefits of upgrading monitoring networks with wider application of high-frequency sampling.


Assuntos
Poluentes da Água/análise , Qualidade da Água , Monitoramento Ambiental , Vitória , Água
3.
J Immunother Cancer ; 9(1)2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33414262

RESUMO

BACKGROUND: Interleukin (IL) 1 released from monocytes/macrophages is one of the critical determinants in mediating the adverse events of chimeric antigen receptor T cell (CAR-T) therapy, including cytokine release syndrome and neurotoxicity. However, the molecular mechanisms of IL-1 production during CAR-T therapy remain unknown. METHODS: The roles of AIM2 and α1-adrenergic receptor (α1-AR) in CAR-T treatment-induced IL-1ß release were evaluated by gene silencing, agonist or antagonist treatment. The phenotype switch of macrophages in response to CAR-T treatment was analyzed concerning cytotoxicity of CAR-T cells and proliferation of activated T cells. RESULTS: This study provided the experimental evidence that CAR-T treatment-induced activation of AIM2 inflammasome of macrophages resulted in the release of bioactive IL-1ß. CAR-T treatment-induced α1-AR-mediated adrenergic signaling augmented the priming of AIM2 inflammasome by enhancing IL-1ß mRNA and AIM2 expression. Meanwhile, tumor cell DNA release triggered by CAR-T treatment potentiated the activation of AIM2 inflammasome in macrophages. Interestingly, an apparent phenotypic switch in macrophages occurred after interacting with CAR-T/tumor cells, which greatly inhibited the cytotoxicity of CAR-T cells and proliferation of activated T cells through upregulation of programmed cell death-ligand 1 (PD-L1) and indoleamine 2,3-dioxygenase (IDO) in the macrophages. Blockade of AIM2 inflammasome or α1-AR reversed the upregulation of PD-L1 and IDO and the phenotypic switch of the macrophages. CONCLUSION: Our study implicates that CAR-T therapy combined with the blockade of AIM2 inflammasome or α1-AR may relieve IL-1ß-related toxic side effects of CAR-T therapy and ensure antitumor effects of the treatment.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Imunoterapia Adotiva/métodos , Interleucina-1beta/metabolismo , Macrófagos/citologia , Neoplasias/imunologia , Receptores Adrenérgicos alfa/metabolismo , Receptores de Antígenos Quiméricos/metabolismo , Antagonistas Adrenérgicos alfa , Antígeno B7-H1/genética , Linhagem Celular Tumoral , Técnicas de Cocultura , Regulação Neoplásica da Expressão Gênica , Humanos , Indolamina-Pirrol 2,3,-Dioxigenase/genética , Macrófagos/imunologia , Neoplasias/genética , Neoplasias/terapia , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia , Células THP-1
4.
Environ Pollut ; 288: 117337, 2021 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-34000444

RESUMO

Water quality monitoring programs often collect large amounts of data with limited attention given to the assessment of the dominant drivers of spatial and temporal water quality variations at the catchment scale. This study uses a multi-model approach: a) to identify the influential catchment characteristics affecting spatial variability in water quality; and b) to predict spatial variability in water quality more reliably and robustly. Tropical catchments in the Great Barrier Reef (GBR) area, Australia, were used as a case study. We developed statistical models using 58 catchment characteristics to predict the spatial variability in water quality in 32 GBR catchments. An exhaustive search method coupled with multi-model inference approaches were used to identify important catchment characteristics and predict the spatial variation in water quality across catchments. Bootstrapping and cross-validation approaches were used to assess the uncertainty in identified important factors and robustness of multi-model structure, respectively. The results indicate that water quality variables were generally most influenced by the natural characteristics of catchments (e.g., soil type and annual rainfall), while anthropogenic characteristics (i.e., land use) also showed significant influence on dissolved nutrient species (e.g., NOX, NH4 and FRP). The multi-model structures developed in this work were able to predict average event-mean concentration well, with Nash-Sutcliffe coefficient ranging from 0.68 to 0.96. This work provides data-driven evidence for catchment managers, which can help them develop effective water quality management strategies.


Assuntos
Solo , Qualidade da Água , Austrália , Monitoramento Ambiental
5.
Biochim Biophys Acta Rev Cancer ; 1874(1): 188378, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32413572

RESUMO

CRISPR/Cas-based genetic perturbation screens have emerged as powerful tools for large-scale identification of new targets for cancer immunotherapy. Various strategies of CRISPR screen have been used for immune-oncology (IO) target discovery. The genomic sequences targeted by CRISPR/Cas system range from coding sequences to non-coding RNA/DNA, including miRNAs, LncRNAs, circRNAs, promoters, and enhancers, which may be potential targets for future pharmacological and therapeutic interventions. Rapid progresses have been witnessed in finding novel targets for enhancing tumor antigen presentation, sensitizing of tumor cells to immune-mediated cytotoxicity, and reinvigorating tumor-specific T cells by using CRISPR technologies. In combination with other strategies, the detailed characteristics of the targets for immunotherapy have been obtained by CRISPR screen. In this review, we present an overview of recent progresses in the development of CRISPR-based screens for IO target identification and discuss the challenges and possible solutions in this rapidly growing field.


Assuntos
Antineoplásicos Imunológicos/uso terapêutico , Biomarcadores Tumorais/genética , Sistemas CRISPR-Cas/genética , Descoberta de Drogas/métodos , Neoplasias/tratamento farmacológico , Animais , Antineoplásicos Imunológicos/farmacologia , Biomarcadores Tumorais/antagonistas & inibidores , Biomarcadores Tumorais/imunologia , Modelos Animais de Doenças , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos/genética , Ensaios de Seleção de Medicamentos Antitumorais/métodos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/imunologia , Genômica/métodos , Humanos , Terapia de Alvo Molecular/métodos , Neoplasias/genética , Neoplasias/imunologia , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia , Evasão Tumoral/efeitos dos fármacos , Evasão Tumoral/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA